How Much Is 300 mcg of Melatonin and Is It Effective?

Three hundred micrograms (mcg) of melatonin equals 0.3 milligrams (mg), roughly one-tenth to one-thirtieth the dose found in most over-the-counter melatonin gummies and tablets sold in the United States. Despite sounding vanishingly small, this amount is backed by solid research as an effective dose for improving sleep, and it’s often called a “physiologic” dose because it raises blood melatonin to levels the body naturally produces at night.

What 300 Micrograms Actually Looks Like

The confusion is understandable. Melatonin supplements sold in U.S. stores and pharmacies typically come in doses of 3 mg, 5 mg, or even 10 mg. A 300 mcg dose is 0.3 mg, so if you’re holding a standard 3 mg tablet, you’d need to somehow take just one-tenth of it. If you’re holding a 5 mg gummy, 300 mcg would be about one-sixteenth of that gummy. In practical terms, you need a product specifically formulated at 300 mcg or 0.3 mg, and these do exist but are harder to find on mainstream shelves.

The gap between what researchers have studied as effective and what supplement companies sell is enormous. Most melatonin studies examining physiologic dosing use 0.1 mg to 0.5 mg, while the majority of consumer products start at 1 mg and go up from there. This mismatch isn’t driven by evidence suggesting higher doses work better. It’s driven by consumer psychology and the supplement market’s tendency to equate “more” with “stronger.”

What the Research Shows About 0.3 mg

The most cited study on this specific dose was conducted in people over 50 years old who had confirmed sleep problems. In a placebo-controlled design, participants received a placebo and three different melatonin doses (0.1 mg, 0.3 mg, and 3.0 mg) for one week each, with sleep measured by polysomnography. The 0.3 mg dose restored sleep efficiency and raised plasma melatonin to normal nighttime levels. It worked primarily in the middle portion of the night, which is when older adults with low natural melatonin tend to wake up.1PubMed. Melatonin treatment for age-related insomnia

What’s striking about that study is that the 3.0 mg dose, which is ten times higher, didn’t produce meaningfully better sleep outcomes than 0.3 mg. The lower dose was enough. Separate research in younger, healthy volunteers comparing 0.3 mg to 1.0 mg found the same pattern: both doses helped people fall asleep faster, with no detectable additional benefit from tripling the dose.

A broader meta-analysis pooling data from multiple trials found that exogenous melatonin in general reduced the time it took to fall asleep by about four minutes, improved sleep efficiency by roughly two percent, and extended total sleep time by about thirteen minutes.2Sleep Medicine Reviews. Effects of exogenous melatonin on sleep: a meta-analysis Those numbers sound modest, and they are. Melatonin isn’t a sedative. It’s a signal molecule that tells your brain’s clock it’s nighttime. The benefit is real but subtle, which is exactly what you’d expect from a hormone working at physiological concentrations.

Why Such a Small Amount Works

Melatonin is produced by the pineal gland, a tiny structure deep in the brain, and its nighttime secretion under normal conditions is measured in picograms per milliliter of blood.3PubMed. Melatonin: Physiological effects in humans The body doesn’t need much of this hormone floating around to get the message. When researchers say 0.3 mg is a “physiologic” dose, they mean it’s the amount that, once swallowed and partially broken down by the liver, raises blood levels to roughly the same range the pineal gland achieves on its own at night.

That liver processing is the key detail. When you swallow melatonin, only about 15 percent of it actually reaches your bloodstream. The rest gets metabolized on its first pass through the liver.4PubMed Central. Bioavailability of Melatonin after Administration of an Oral Prolonged-Release Tablet and an Immediate-Release Sublingual Spray in Healthy Male Volunteers So when you take 0.3 mg by mouth, the amount that actually enters circulation is in the range of 45 micrograms, which is precisely the neighborhood of normal nighttime melatonin levels. Take 5 mg or 10 mg by mouth, and you’re flooding your receptors with concentrations many times above what the brain ever produces. The receptors can become less responsive, and the timing signal gets blurred rather than sharpened.

Sublingual sprays and dissolvable tablets partly bypass that liver metabolism because they absorb through the lining of your mouth. If you’re using a sublingual product, the effective blood level from the same labeled dose will be higher than from a swallowed tablet. That’s worth knowing when comparing products.

Timing Matters More Than Dose

Melatonin’s main job isn’t knocking you out. It’s adjusting the position of your internal clock. Researchers have mapped out what’s called a phase-response curve: melatonin taken in the afternoon or early evening advances your clock, making you feel sleepy earlier and wake earlier. Taken in the morning, it delays your clock, pushing your sleep-wake cycle later.5PubMed. Melatonin shifts human circadian rhythms according to a phase-response curve This pattern is nearly the opposite of what bright light does to the clock, which makes sense since melatonin is the body’s darkness signal.

A study comparing 0.5 mg and 3.0 mg melatonin found that both doses produced similarly sized clock shifts when given at their optimal times. The lower dose needed to be taken slightly later to hit its peak effect, about two to four hours before the body’s natural melatonin onset. But the magnitude of the shift was comparable to the sixfold-higher dose.6PubMed Central. Human phase response curves to three days of daily melatonin: 0.5 mg versus 3.0 mg This is the clearest evidence that for circadian adjustment, which covers jet lag, shift-work recovery, and delayed sleep phase disorder, the timing of the dose matters far more than the size of the dose.

For someone trying to fall asleep earlier, taking 0.3 mg about two to four hours before the desired bedtime tends to work well. Taking it right at bedtime, which is what most people do, may help a bit with sleep onset but misses the larger chronobiotic window. Preliminary research also suggests that combining low-dose melatonin with simple behavioral measures, like dimming lights in the evening and keeping a consistent time in bed, may improve circadian parameters even without precisely measuring each person’s internal clock timing.7PubMed. Low-dose exogenous melatonin plus evening dim light and time in bed scheduling advances circadian phase irrespective of measured or estimated dim light melatonin onset time: preliminary findings

The Label Accuracy Problem

Even if you decide 0.3 mg is the right dose, actually getting 0.3 mg into your body is trickier than it should be. In a 2023 analysis of melatonin gummies sold in the U.S., the actual melatonin content ranged from 74 percent to 347 percent of what the label claimed. Out of 25 products tested, only three were within 10 percent of the declared quantity.8JAMA. Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US

An earlier Canadian study found even wider variation. Melatonin content in supplements ranged from 83 percent less than claimed to 478 percent more, and lot-to-lot variation within a single product line differed by as much as 465 percent. The researchers found no consistent pattern by manufacturer or product type.9PubMed Central. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content In practical terms, a bottle labeled 0.3 mg could contain anywhere from a tiny fraction of that to more than a full milligram per dose, and you’d have no way of knowing without independent lab testing.

This issue exists because melatonin is regulated as a dietary supplement in the United States, which means it doesn’t go through the same manufacturing quality checks as prescription drugs. If accurate dosing matters to you, and at physiologic doses it absolutely does, looking for products with third-party testing verification (USP, NSF, or ConsumerLab seals) is one way to improve your odds of getting what the label says.

Side Effects at Higher Versus Lower Doses

Melatonin is generally well tolerated, but dose matters for side effects. A systematic review and meta-analysis of higher melatonin doses in adults found that melatonin increased the risk of side effects like drowsiness, headache, and dizziness compared to placebo.10Journal of Pineal Research. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis At physiologic doses like 0.3 mg, these effects are uncommon. The reason is straightforward: 0.3 mg brings blood levels into the normal nighttime range, while 5 or 10 mg pushes levels far above it, and melatonin lingers in the blood longer at those concentrations. Next-day grogginess, the most common complaint, is essentially a hangover from melatonin levels that haven’t cleared by morning.

There’s also a paradox that many people experience but few discuss. Taking too much melatonin can actually worsen sleep. Supraphysiologic doses can spill melatonin into the morning hours, desynchronizing the very clock signal the hormone is supposed to set. Some people who think melatonin “doesn’t work for them” have only ever tried 5 mg or higher and might respond quite differently to a fraction of that dose.

Long-Term Use and Tolerance

A reasonable concern with any sleep aid is whether it stops working over time or causes withdrawal symptoms when you stop. The evidence on melatonin is reassuring on both fronts. A long-term open-label study of prolonged-release melatonin found no evidence of tolerance during extended use, no rebound insomnia after discontinuation, and no suppression of the body’s own melatonin production.11PubMed Central. Prolonged-release melatonin for insomnia – an open-label long-term study of efficacy, safety, and withdrawal Participants actually reported residual benefit after stopping, meaning their sleep continued to be better than baseline even once they quit taking it.

A separate evaluation looking at treatment over six months found the same pattern: improvements held steady or even increased over time, with no tolerance, withdrawal symptoms, or rebound insomnia.12PubMed. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response Additional review work in older patients confirmed the absence of dependence.13PubMed. Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years This stands in stark contrast to prescription sleep drugs like benzodiazepines or z-drugs, where tolerance and dependence are well-documented concerns. Melatonin at low doses appears to work more like restoring a missing signal than like sedating the brain, which may explain why the body doesn’t adapt against it the way it does with sedatives.

Older Adults Versus Younger People

The strongest evidence for 0.3 mg melatonin comes from older adults, and that makes biological sense. Natural melatonin production declines with age, so older people are more likely to have a genuine deficit that a physiologic dose can correct. The Zhdanova study found that older adults with confirmed low melatonin and poor sleep responded well to 0.3 mg, while those who already slept normally showed less benefit.1PubMed. Melatonin treatment for age-related insomnia

A systematic review of melatonin dosing in older adults recommended using the lowest possible dose of immediate-release melatonin to mimic the body’s normal rhythm and avoid prolonged above-normal blood levels.14PubMed. Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature For younger adults whose natural melatonin production is intact, the benefit of supplementation is less clear-cut. Melatonin can still help with circadian misalignment issues like jet lag or a delayed sleep schedule, but a young person with normal melatonin levels and a healthy clock may not notice much from any dose.

Children present a different picture. Melatonin use in pediatric populations has risen sharply, and reports of side effects and overdoses have increased alongside that trend.15PubMed Central. Melatonin Use in Pediatrics: A Clinical Review on Indications, Multisystem Effects, and Toxicity Because children’s bodies are smaller and their hormonal systems are still developing, even standard adult doses can be disproportionately large. If a pediatrician recommends melatonin for a child, the dose is typically very low, and the label accuracy problem discussed earlier becomes even more concerning when the intended dose is already tiny.

How Melatonin Is Regulated Around the World

One reason the U.S. supplement market is flooded with high-dose melatonin is that melatonin is classified as a dietary supplement in the United States, meaning it faces minimal pre-market scrutiny. The situation varies dramatically elsewhere. In Australia, the United Kingdom, and Switzerland, melatonin is a prescription medicine and isn’t allowed in dietary supplements at all. Within the European Union, regulation depends on the country: prolonged-release melatonin is generally treated as a prescription medicine, while immediate-release forms are either prescription-only or available over the counter depending on the nation. Even where dietary supplements containing melatonin are permitted, the maximum allowed dose is far lower than what U.S. products commonly contain. France, which has the highest ceiling in the EU, caps dietary supplement melatonin at 2 mg per daily dose.16PubMed Central. Validated UHPLC Methods for Melatonin Quantification Reveal Regulatory Violations in EU Online Dietary Supplements Commerce

This patchwork regulation helps explain why the idea of 300 mcg melatonin seems startlingly low to many Americans. If the only products you’ve ever seen on a drugstore shelf start at 3 mg, then 0.3 mg looks like a homeopathic dose. But in countries where melatonin is treated as a real pharmaceutical, doses in the 0.3 to 2 mg range are standard precisely because the clinical evidence supports them.

Beyond Sleep

Melatonin research has branched well beyond insomnia. A recent dose-response meta-analysis of randomized trials found that melatonin supplementation produced small but statistically significant reductions in several cardiometabolic markers, including systolic blood pressure, fasting blood glucose, LDL cholesterol, total cholesterol, and certain inflammatory markers like C-reactive protein.17PubMed Central. Comprehensive Effects of Melatonin Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose–Response Meta-Analysis These effects are modest and not large enough to replace standard treatments for high blood pressure or high cholesterol, but they hint at melatonin’s broader role as an antioxidant and anti-inflammatory molecule. Much of this research used doses above the physiologic range, so whether 0.3 mg produces the same metabolic effects remains an open question. For now, the clearest reason to consider 300 mcg melatonin is for what it does best: gently nudging your circadian clock toward sleep without overwhelming the system that makes the signal meaningful in the first place.